WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from the originator

By WHO; 

WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at the highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date.


Only 29% of hospitalized COVID patients were fully well one year on - study

By Daily Monitor; 

Not even one in four people have completely recovered from Covid a full year after being hospitalized with the disease, a UK study indicated Sunday, warning that long Covid could become a common condition.


The longest COVID infection lasted more than 16 months, tests show

By BBC; 

UK doctors believe they have documented the longest Covid infection on record - a patient they treated who had detectable levels of the virus for more than 16 months, or 505 days, in total. 


Hepatitis cases detected in children in Europe and the US

By BBC; 

Health officials say they are now investigating unexplained cases of hepatitis in children in four European countries and the US.


111 theatres at Health Centre IVs not operational

By New Vision;

A total of 111 theatres at HCIVs have remained non-functional due to a lack of funds to operationalize them. 


Unvaccinated pregnant women at risk of stillbirths

By Daily Monitor; 

A study of pregnancies complicated by Covid-19 infection identified placental abnormalities, suggesting that inflammation might occur with maternal Covid-19 infection. A high concentration of the Covid-19 virus in the mother’s blood makes it more likely to cause stillbirths.


UVRI to investigate low Covid-19 cases

The Uganda Virus Research Institute has started a study to investigate why the country and some of its neighbors are reporting low COVID-19 cases.


Why more Kenyan men are shooting blanks

By Daily Monitor;  

Experts say a third of today’s infertility cases arise from male factors and in Kenya, sperm quality and volumes are fast dwindling 


Johnson & Johnson cuts forecasts, suspends COVID vaccine sales guidance

By The Independent; 

Johnson & Johnson expects to report 94.8 billion to 95.8 billion U.S. dollars of sales in 2022, lower than a projection of 95.9 billion to 96.9 billion dollars made in January 


WHO approves single-dose cervical cancer jab

By The East African; 

The World Health Organization (WHO) has approved the use of single human papillomavirus (HPV) vaccine dose, saying, it’s highly effective in preventing the virus that causes cervical cancer.